Tower Research Capital (TRC)’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-8,937
Closed -$804 6417
2023
Q3
$804 Buy
8,937
+1,080
+14% +$97 ﹤0.01% 5473
2023
Q2
$723 Sell
7,857
-54
-0.7% -$5 ﹤0.01% 5538
2023
Q1
$2K Buy
7,911
+11
+0.1% +$3 ﹤0.01% 5472
2022
Q4
$2K Sell
7,900
-524
-6% -$133 ﹤0.01% 5524
2022
Q3
$2K Buy
8,424
+5,995
+247% +$1.42K ﹤0.01% 5718
2022
Q2
$2K Sell
2,429
-1,613
-40% -$1.33K ﹤0.01% 5711
2022
Q1
$3K Sell
4,042
-1,566
-28% -$1.16K ﹤0.01% 5497
2021
Q4
$6K Sell
5,608
-786
-12% -$841 ﹤0.01% 5118
2021
Q3
$11K Buy
+6,394
New +$11K ﹤0.01% 4297
2021
Q2
Sell
-783
Closed -$2K 6344
2021
Q1
$2K Buy
+783
New +$2K ﹤0.01% 5133
2020
Q4
Sell
-1,317
Closed -$4K 5657
2020
Q3
$4K Sell
1,317
-2,241
-63% -$6.81K ﹤0.01% 4472
2020
Q2
$14K Buy
+3,558
New +$14K ﹤0.01% 3887
2018
Q2
Sell
-744
Closed -$5K 4353
2018
Q1
$5K Buy
744
+493
+196% +$3.31K ﹤0.01% 2755
2017
Q4
$2K Sell
251
-36
-13% -$287 ﹤0.01% 3290
2017
Q3
$2K Sell
287
-2,167
-88% -$15.1K ﹤0.01% 3621
2017
Q2
$25K Buy
+2,454
New +$25K ﹤0.01% 1117
2016
Q3
Sell
-1,953
Closed -$21K 4946
2016
Q2
$21K Buy
+1,953
New +$21K ﹤0.01% 2210
2016
Q1
Sell
-874
Closed -$23K 5373
2015
Q4
$23K Buy
874
+408
+88% +$10.7K ﹤0.01% 1173
2015
Q3
$22K Buy
466
+304
+188% +$14.4K ﹤0.01% 1666
2015
Q2
$5K Buy
162
+38
+31% +$1.17K ﹤0.01% 3296
2015
Q1
$4K Sell
124
-150
-55% -$4.84K ﹤0.01% 3466
2014
Q4
$10K Sell
274
-3,299
-92% -$120K ﹤0.01% 2190
2014
Q3
$94K Buy
3,573
+2,649
+287% +$69.7K 0.01% 1033
2014
Q2
$27K Buy
+924
New +$27K ﹤0.01% 1676
2014
Q1
Sell
-113
Closed -$5K 5243
2013
Q4
$5K Buy
113
+107
+1,783% +$4.74K ﹤0.01% 3571
2013
Q3
$0 Buy
+6
New ﹤0.01% 5010